Interactive Guided Ultrasound Examinations Done by Non-experts of Ultrasound Imaging

NCT ID: NCT03642730

Last Updated: 2021-02-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

55 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-12-01

Study Completion Date

2021-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective study is a pilot study for evaluating a guidance system that aims to facilitate high-quality echocardiographic acquisitions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objective of this study is to assess the feasibility for non-expert users (medical professionals but non-certified sonographers) to acquire parasternal, apical and subcostal views of suitable quality by using an existing ultrasound device (CE-marked, available in the market) and an additional guidance system (software prototype + probe motion tracking device). Such a system will help the user to place the probe on the patient and provide guidance for optimal acquisition of parasternal, apical and subcostal views.

The secondary objective of this study is to assess the feasibility for non-expert users to reproduce a simple clinical protocol by using an existing ultrasound device and the same additional guidance system.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Disease Heart Failure Cardiac Ischemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Masking is not applicable, since software study

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Scanned patients

Scanned patients TransThoracic Echocardiography Diagnostic Test: TransThoracic Echocardiography imaging synchronized with additional external sensors

Group Type EXPERIMENTAL

TransThoracic Echocardiography imaging

Intervention Type DEVICE

ultrasound scanning

Non-expert scanning volunteers

Non-expert scanning volunteers (among the medical staff at the clinical site) TransThoracic Echocardiography Diagnostic Test: TransThoracic Echocardiography imaging synchronized with additional external sensors

Group Type EXPERIMENTAL

TransThoracic Echocardiography imaging

Intervention Type DEVICE

ultrasound scanning

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TransThoracic Echocardiography imaging

ultrasound scanning

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All volunteers must have the ability to provide informed consent.
* All volunteers should be affiliated to the French Social Security.
* All volunteers will be scheduled for a routine transthoracic echocardiography exam in the echocardiography laboratory at the investigation site as part of standard care.

Exclusion Criteria

* Subjects with congenital heart diseases (except bicuspid aortic valve)
* Pregnant women
* Adults lacking decisional capacity
* Adults placed under a legal protection regime (guardianship, curatorship, judicial protection)
* Adults not affiliated to the French Social Security
* Adults in emergent or critical condition
* Adults with active pain in the intended scanning region
* Adults with active skin disease or lesions in the intended scanning region
* Adults with allergy/sensitivity to ultrasound gel
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Philips Healthcare

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eric Saloux, MD

Role: PRINCIPAL_INVESTIGATOR

Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Caen Service de Cardiologie

Caen, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ICBE-2-11984

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Concordance AUTOFEVG
NCT04641169 COMPLETED NA
Guided Placement of CRT-Leads
NCT00764075 COMPLETED NA